Skip to main content

Table 1 Descriptive variables on the experimental day (at week 8)

From: Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats

 

Control

Diabetic

TETA-treated diabetic

P

Body-weight (g)

438 ± 7 (28)

247 ± 8 (28) a

269 ± 5 (26) b, c

<0.0001

Heart-weight (g)

1.60 ± 0.07 (24)

1.24 ± 0.06 (24) a

1.25 ± 0.05 (20) c

<0.0001

Tibial length (cm)

4.23 ± 0.04 (13)

3.86 ± 0.06 (16) a

3.87 ± 0.06 (20) c

<0.0001

Heart weight/Body-weight (x 10 3 )

3.7 ± 0.1 (23)

5.3 ± 0.2 (21) a

5.0 ± 0.2 (20) c

<0.0001

Heart weight/ (Tibial length) 2 (mg/cm 2 )

94 ± 4 (13)

90 ± 5 (13)

84 ± 3 (20)

0.23

Blood glucose (mmol/L)

4.7 ± 0.1 (24)

30.8 ± 0.8 (30) a

32.2 ± 0.7 (26) c

<0.0001

Heart rate (min -1 )

390 ± 9 (11)

311 ± 6 (18) a

315 ± 12 (10) c

<0.0001

Corrected QT interval (ms)

177 ± 4 (11)

192 ± 4 (18) a

138 ± 14 (10) b

0.001

  1. Data are means ± SEM. Numbers of animals were as shown in parentheses. P-values are by Kruskal-Wallis one-way ANOVA with Dunn’s multiple-comparisons test or one-way ANOVA with the Holm-Sidak method as appropriate; a, b, c, significant differences: a, Control vs Diabetic groups; b, Diabetic vs TETA-treated diabetic; c, Control vs TETA-treated Diabetic.